M. Saleem Ismail, M.B.B.S.

M. Saleem Ismail, M.B.B.S.

Contact Information

1200 Jefferson Road
Suite 310
Rochester, NY 14623

Office: (585) 760-6221
Fax: (585) 482-2275

Journal Articles

Showing all 10 journal articles available.

2008 Jul
, Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M. "Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib." Archives of neurology. 2008 Jul; 65(7):896-905. Epub 2008 May 12.
2007 Jul
Ismail MS, Dagerman K, Tariot PN, Abbott S, Kavanagh S, Schneider LS. "National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics." Current Alzheimer research. 2007 Jul; 4(3):325-35.
2006 Nov 17
. "Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)." PLoS clinical trials. 2006 Nov 17; 1(7):e33. Epub 2006 Nov 17.
2006 Oct 12
Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA, . "Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease." The New England journal of medicine. 2006 Oct 12; 355(15):1525-38.
Ismail MS. "Long-term benefits of early pharmacologic treatment in Alzheimer's disease. Interview by Frederic Flach." Essential psychopharmacology. 2005 6(4):227-37.
Ismail MS, Richard IH. "A reality test: How well do we understand psychosis in Parkinson's disease?" The Journal of neuropsychiatry and clinical neurosciences. 2004 16(1):8-18.
Tariot PN, Profenno LA, Ismail MS. "Efficacy of atypical antipsychotics in elderly patients with dementia." The Journal of clinical psychiatry. 2004 65 Suppl 11:11-5.
Schneider LS, Ismail MS, Dagerman K, Davis S, Olin J, McManus D, Pfeiffer E, Ryan JM, Sultzer DL, Tariot PN. "Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial." Schizophrenia bulletin. 2003 29(1):57-72.
Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S. "Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales." Advanced drug delivery reviews. 2002 54(12):1567-77.
Tariot PN, Ismail MS. "Use of quetiapine in elderly patients." The Journal of clinical psychiatry. 2002 63 Suppl 13:21-6.


Lisa Boyle, MD and Saleem Ismail, MD, Anton Porsteinsson, AP. "The Clinical Evaluation of Dementia". In Principles and Practice of Geriatric Psychiatry 2nd Edition. Marc Agronin & Gabe J. Maletta. Philadelphia: Lippincott, Williams and Wilkins, 2009.
Boyle L, Ismail MS, Porsteinsson AP. "The Dementia Work-up". In Principles and Practice of Geriatric Psychiatry. Marc Agronin & Gabe J. Maletta. Philadelphia, PA: Lippincott, Williams and Wilkins, 2006. 137-152
Profenno LA, Tariot PN, Ismail MS. "Treatments for Behavioral and Psychological Symptoms in Alzheimer's Disease and Other Dementias". Dementia. Alistair Burns, John O'Brien & David Ames. London: Edward Arnold Limited, 2005. 482-498
Porsteinsson A, Ryan JM, Ismail MS, Tariot PN. "Non-Psychotic Behavioral Disturbance in Dementia". Handbook of Dementia: Psychological, Psychiatric and Neurological Perspectives. Lichtenberg PA, Murman DL, Mellow AM. Hoboken, NJ: John Wiley & Sons Inc., 2003. 335-357
Ismail MS, Tariot,PN. "Galantamine in Treatment of Alzheimer's Disease". In Alzheimer's Disease: A Physician's Guide to Practical Management. Ralph W. Richter, Brigitte Z. Richter. Totowa, NJ: Humana Press Inc., 2003. 193-202